<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04688190</url>
  </required_header>
  <id_info>
    <org_study_id>CHOICE-MI</org_study_id>
    <nct_id>NCT04688190</nct_id>
  </id_info>
  <brief_title>CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry</brief_title>
  <acronym>CHOICE-MI</acronym>
  <official_title>Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multinational, investigator-initiated, retrospective study aims to investigate outcomes&#xD;
      of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to&#xD;
      those screened for TMVI but deemed ineligible, who subsequently underwent interventional&#xD;
      mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mitral insufficiency grade 2+ or more</measure>
    <time_frame>12 months</time_frame>
    <description>Mitral insufficiency measured by transthoracic echocardiography. Assessment of MI severity according to current guidelines (ESC/EACTS and ACC/AHA) for valvular heart disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from device-related complications</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined all-cause mortality or rehospitalization for congestive heart failure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization for congestive heart failure</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of new-onset or worsening signs and symptoms of heart failure that required urgent therapy and resulted in hospitalization, e.g. as assessed by patient interviews.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined cardiovascular mortality or rehospitalization for congestive heart failure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned mitral valve intervention</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of unplanned surgical or transcatheter re-intervention, heart transplantation or left ventricular assist device implantation, e.g. as assessed by patient interviews.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined all-cause mortality, rehospitalization for congestive heart failure or unplanned mitral valve intervention</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined cardiovascular mortality, rehospitalization for congestive heart failure or unplanned mitral valve intervention</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) stage III or IV</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of New York Heart Association (NYHA) classification stage (in- or outpatient) after 12 months follow-up, as assessed by patient interviews.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>Transcatheter Mitral Valve Implantation (TMVI)</arm_group_label>
    <description>Patients with successful TMVI screening, who underwent Transcatheter Mitral Valve Implantation subsequently. All devices may be included.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional mitral valve edge-to-edge repair (E2E)</arm_group_label>
    <description>Patients with TMVI screening failure, who subsequently underwent interventional mitral valve edge-to-edge repair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mitral valve surgery (Surgery)</arm_group_label>
    <description>Patients with TMVI screening failure, who subsequently underwent mitral valve surgery (i.e., mitral valve repair or replacement).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical therapy (OMT)</arm_group_label>
    <description>Patients with TMVI screening failure, who subsequently underwent conservative or optimal medical therapy (OMT).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This study aimes to include all patients with significant mitral insufficiency, who&#xD;
        underwent screening for possible transcatheter mitral valve implantation (TMVI),&#xD;
        irrespective of the subsequent therapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinically significant mitral insufficiency&#xD;
&#xD;
          -  patient underwent screening for TMVI&#xD;
&#xD;
          -  echocardiography data at baseline (and after TMVI, E2E and surgery)&#xD;
&#xD;
          -  follow-up of at least 30 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - age under 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lenard Conradi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Heart and Vascular Center Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Modine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastian Ludwig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Heart and Vascular Center Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walid Ben Ali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alison Duncan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Brompton Hospital London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilbert Tang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Medical Center, NYC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan F Granada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Research Foundation, New York, USA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastian Ludwig, MD</last_name>
    <phone>+4915222816168</phone>
    <email>se.ludwig@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Walid Ben Ali, MD</last_name>
    <phone>+15145611037</phone>
    <email>dr.walidbenali@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj Makkar, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Sung-Han Yoon, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsuyoshi Kaneko, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Pinak Shah, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Reardon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Muller, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Heart Center</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Fam, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John G Webb, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Sondergaard, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bourdeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Modine, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augustin Coisne, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Civils Hospices of Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Francois Obadia, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Dumonteil, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HDZ Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Rudolph, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Sabine Bleiziffer, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>German Heart Center Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Kempfert, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Axel Unbehaun, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Heart Center Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nickenig, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Marcel Weber, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Adam, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Goethe-Universität - University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Walther, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Heart and Vascular Center Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Ludwig, MD</last_name>
    </contact>
    <investigator>
      <last_name>Lenard Conradi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Center of the University Medical Center Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Stephan von Bardeleben, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Felix Kreidel, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>German Heart Centre Munich</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik Ruge, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Rüdiger Lange, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>LMU Munich</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Hausleiter, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Raffaele University Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Denti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rikshospitalet, Oslo University Hospital (OUS)</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gry Dahle, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabien Praz, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Mirjam Wild, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>USZ Zurich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Pozzoli, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Maurizio Taramasso, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Duncan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Thomas' Hospital - London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Redwood, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Omar Chehab, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Norway</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>December 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Sebastian Ludwig</investigator_full_name>
    <investigator_title>Sebastian Ludwig, M.D., Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

